Cargando…
4-1BB Signaling Activates the T Cell Factor 1 Effector/β-Catenin Pathway with Delayed Kinetics via ERK Signaling and Delayed PI3K/AKT Activation to Promote the Proliferation of CD8(+) T Cells
4-1BB (CD137), an inducible costimulatory molecule, strongly enhances the proliferation and effector function of CD8(+) T cells. Since the serine/threonine kinase, glycogen synthase kinase-3 (GSK-3), is involved in a variety of signaling pathways of cellular proliferation, migration, immune response...
Autores principales: | Lee, Do Y., Choi, Beom K., Lee, Don G., Kim, Young H., Kim, Chang H., Lee, Seung J., Kwon, Byoung S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708905/ https://www.ncbi.nlm.nih.gov/pubmed/23874982 http://dx.doi.org/10.1371/journal.pone.0069677 |
Ejemplares similares
-
4-1BB Signaling Breaks the Tolerance of Maternal CD8(+) T Cells That Are Reactive with Alloantigens
por: Kim, Kwang H., et al.
Publicado: (2012) -
4-1BB Signaling Enhances Primary and Secondary Population Expansion of CD8(+) T Cells by Maximizing Autocrine IL-2/IL-2 Receptor Signaling
por: Oh, Ho S., et al.
Publicado: (2015) -
Chronic activation of 4-1BB signaling induces granuloma development in tumor-draining lymph nodes that is detrimental to subsequent CD8(+) T cell responses
por: Kim, Seon-Hee, et al.
Publicado: (2020) -
Chronic Alcohol Ingestion Delays T Cell Activation and Effector Function in Sepsis
por: Margoles, Lindsay M., et al.
Publicado: (2016) -
Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors
por: Eom, Hyeon-Seok, et al.
Publicado: (2016)